Based on recent data, Royalty Pharma plc (RPRX) shows an Average True Range (ATR) of 0.83 and an Enterprise Value of 18.16B. Its average trading volume over the past 3 months is 3.48M, indicating liquidity. These fundamental metrics provide insight into RPRX's underlying financial health and market activity.
| ATR | 0.83 |
| Enterprise Value | 18.16B |
| Avg Vol (3 Months) | 3.48M |
| Avg Vol (10 Days) | 4.13M |
Royalty Pharma plc (RPRX) technical indicators as of March 22, 2026: the SMA 20 is 2.49%, SMA 50 at 9.41%, and SMA 200 at 20.66%. The RSI 14 value is 71.97, suggesting its current momentum. These technical analysis signals help assess RPRX's price trends and potential future movements.
| SMA 20 | 2.49% |
| SMA 50 | 9.41% |
| SMA 200 | 20.66% |
| RSI 14 | 71.97 |
Royalty Pharma plc (RPRX) stock performance overview as of March 22, 2026: The 52-week high is $47.65 (currently -1.69% below), and the 52-week low is $29.66 (currently 52.93% above). Over the past year, RPRX's performance is 26.3%, compared to the S&P 500's 16.63% change.
| 52-Week High | 47.65 |
| 52-Week High Chg | -1.69% |
| 52-Week Low | 29.66 |
| 52-Week Low Chg | +52.93% |
| S&P 500 52-Week Chg | 16.63% |
According to market data, Royalty Pharma plc (RPRX) stock's recent performance metrics show that over the last month, RPRX is 2.04%, with a Year-to-Date (YTD) performance of 1.16%. Over the past year, the stock has seen a 26.3% change. These figures summarize RPRX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 46.44 | 47.65 | 47.65 | 47.65 | 47.65 | 47.65 |
| Low | 44.73 | 44.68 | 37.83 | 34.63 | 29.66 | 38.29 |
| Performance | -2.91% | +2.04% | +5.62% | +9.65% | +26.30% | +1.16% |
According to current financial data, RPRX stock's P/E (TTM) ratio is 25.41, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for RPRX, including P/S (8.17), P/B (3.02), and P/FCF (7.81), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | RPRX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 25.41 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 8.17 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 3.02 | 4.42 | 5.83 | 4.56 |
| P/FCF (TTM) | 7.81 | -35.83 | -188.84 | 31.7 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep